Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants — Stella

Recruiting

Back to Healthy Participants trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

ICON Clinical Research: Lenexa, Lenexa, Kansas

ICON Clinical Research: Salt Lake City, Salt Lake City, Utah

Key details

Phase

Early testing

Sponsor

Shionogi

Enrollment target

~98 participants

Started

July 2025

Primary completion

May 2027

Age range

18 Years – 55 Years

Sex

Male only

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov